Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell membranes and reactive oxygen species (ROS) in ocular tissues refers to the physiological and pathological interaction between highly reactive oxygen-containing molecules and the lipid bilayers of cells within the eye, including the retina, lens, and cornea. ROS, such as superoxide and hydrogen peroxide, are generated as byproducts of mitochondrial metabolism or induced by external stressors like ultraviolet (UV) radiation and high oxygen tension (Nita & Grzybowski, 2016). When the production of ROS exceeds the capacity of the eye's endogenous antioxidant defenses, oxidative stress occurs, leading to the peroxidation of polyunsaturated fatty acids in cell membranes, which compromises structural integrity and leads to cell death (Gaschler & Stockwell, 2017). This oxidative damage is a primary driver in the pathogenesis of major ocular diseases, including age-related macular degeneration (AMD), cataracts, and glaucoma (Beatty et al., 2000). Therapeutic strategies, such as the AREDS2 formulation, utilize antioxidants like lutein and zeaxanthin to scavenge ROS and mitigate membrane damage (Chew et al., 2013). Because this term describes a broad pathological environment and a set of chemical interactions rather than a single protein or receptor, it is classified as a biological process rather than a discrete molecular target.
Neutralization of free radicals (radical scavenging), inhibition of lipid peroxidation, and enhancement of endogenous antioxidant enzyme activity to protect ocular cell membranes from structural damage.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell membranes and reactive oxygen species in ocular tissues.